Nexium and Edecrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nexium (esomeprazole magnesium) and Edecrin (ethacrynic acid). Common drug interactions include confusional state among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Nexium and Edecrin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,677 Nexium users. Check the latest studies of Nexium.

What is Edecrin?

Edecrin has active ingredients of ethacrynic acid. It is often used in fluid retention. eHealthMe is studying from 252 Edecrin users. Check the latest studies of Edecrin.

On Jul, 18, 2026

18 people who take Nexium and Edecrin together, and have interactions are studied.

What are the common drug interactions of Nexium and Edecrin, by gender? *:

female:

Confusional state
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Depression
Fall
Generalised oedema (swelling all over the body)
Hip fracture
Hyperhidrosis (abnormally increased sweating)
Injury
Lung disorder (lung disease)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

male:

Asthma
Blood potassium decreased
Incisional hernia (hernia caused by an incompletely-healed surgical wound)
Joint injury
Liver disorder (liver diseases)
Malaise (a feeling of general discomfort or uneasiness)
Migraine (headache)
Muscle spasms (muscle contraction)
Osteitis deformans (a disease of bone occurring in the middle aged and elderly; excessive bone destruction sometimes leading to bone pain)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)

What are the common drug interactions of Nexium and Edecrin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Eosinophilia (eosinophil count in the peripheral blood exceeds)

20-29:

n/a

30-39:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Injury
Pain
Pulmonary embolism (blockage of the main artery of the lung)

40-49:

Cardiac disorder
Cardiac failure
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diarrhoea
Impaired work ability
Malaise (a feeling of general discomfort or uneasiness)
Oedema peripheral (superficial swelling)
Pain
Pericardial effusion (fluid around the heart)
Renal failure (kidney dysfunction)

50-59:

Drug ineffective
Asthma
Blood potassium decreased
Blood pressure inadequately controlled
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cough
Eating disorder
Fall
Gastrointestinal inflammation (inflammation of stomach and intestine)
Headache (pain in head)

60+:

Cataract (clouding of the lens inside the eye)
Neuropathy peripheral (surface nerve damage)
Gait disturbance
Insomnia (sleeplessness)
Asthenia (weakness)
Back pain
Confusional state
Depression
Drug ineffective
Fall

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 33.33%
Oedema (fluid collection in tissue): 4 people, 22.22%
Immune System Disorder: 2 people, 11.11%
Depression: 1 person, 5.56%
Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 1 person, 5.56%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.56%
Fatigue (feeling of tiredness): 1 person, 5.56%
Dry Skin: 1 person, 5.56%
Drug Hypersensitivity: 1 person, 5.56%
Weakness: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Nexium and Edecrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously